UC, Berkeley appeals against PTAB CRISPR decision – Life Sciences Intellectual Property Review (subscription)
Life Sciences Intellectual Property Review (subscription) |
UC, Berkeley appeals against PTAB CRISPR decision
Life Sciences Intellectual Property Review (subscription) The University of California (UC), Berkeley has filed a brief at the US Court of Appeals for the Federal Circuit to appeal against a patent decision on the CRISPR/Cas9 technology. CRISPR/Cas9 is a gene-editing technique that can target and modify DNA … |
